Concepedia

Victoria S. Chua

VS

Statistics

Publications

6

Citations

238

H-Index

6

Active since

2005

Affiliations

Sarcoma Oncology Center(Current)

University of Maryland, Baltimore

Victoria S. Chua is an author at Sarcoma Oncology Center specializing in pharmacology, oncology, and medicine.

ORCID

Publications per year

2005–2022

6

Publications

6

Advanced Phase I/II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Gemcitabine-resistant Metastatic Pancreatic Cancer

Sant P. Chawla, Victoria S. Chua, Lita Fernandez et al. · Molecular Therapy · 2009 · 79 citations · Full text

, , +17

Phase I/II and Phase II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Chemotherapy-resistant Sarcoma and Osteosarcoma

Sant P. Chawla, Victoria S. Chua, Lita Fernandez et al. · Molecular Therapy · 2009 · 76 citations · Full text

, , +17

A phase 1B/2 study of aldoxorubicin in patients with soft tissue sarcoma

Sant P. Chawla, Victoria S. Chua, Andrew Hendifar et al. · Cancer · 2014 · 24 citations · Full text

, , +15

A phase II study of AP23573 (an mTOR inhibitor) in patients (pts) with advanced sarcomas

Sant P. Chawla, Kamalesh K. Sankhala, Victoria S. Chua et al. · Journal of Clinical Oncology · 2005 · 22 citations

, , +17

Early response evaluation of therapy with AP23573 (an mTOR inhibitor) in sarcoma using [<sup>18</sup>F]2-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) scan

Kamalesh K. Sankhala, Sheema Chawla, Andrei Iagaru et al. · Journal of Clinical Oncology · 2005 · 19 citations

, , +17

1–5 of 6